| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.008 | 0.9 |